Reach Through Equitable Implementation in Utah

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Utah

About this trial

The goal of this pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial is to increase the reach of existing evidence-based interventions (EBIs) for tobacco cessation and to mitigate the impact of adverse Social Drivers of Health (SDOH) among safety-net healthcare system patients who live in persistent poverty (PP) census tracts.

Aim 1: Test the ability of patient-level Conversational Agents (CA) \& Patient Navigation (PN) dissemination strategies to increase the Reach (primary outcome) of evidence-based tobacco cessation treatment delivered via the Utah Tobacco and Nicotine Quit Services (Quit Services) among Community Health Center (CHC) patients who use tobacco and live in persistent poverty census tracts. Secondary analyses will examine the outcome of Reach of services for SDOH among these patients and will evaluate both 1) patient-level CA and PN dissemination strategies and 2) a clinic-level implementation strategy using a pre-post design.

Aim 2: Explore contextual factors (e.g., clinic size, patient composition, rurality, patient demographics) related to the Reach, Adoption, Implementation, and potential Maintenance of strategies.

Aim 3: Determine the cost-effectiveness of clinic and patient-level strategies based on Quit Services enrollment and service receipt for SDOH.

This trial implements a clinic-level implementation strategy, Ask-Advise-Connect (AAC), to address tobacco cessation and needs around social drivers of health for patients in all participating clinics. Eligible patients who are not enrolled in Quit Services four weeks after the clinical encounter, will receive text messages from a chatbot offering information and connections to the Quit Services and patient navigation support from a Community Health Worker.

Eligibility criteria

Qualifiers

≥ 18 years of age

Speak English or Spanish

Currently use tobacco

Live in a persistent poverty census tract

Disqualifiers

Opt-out of study

Trial design

Treatments tested in this trial

  • Clinic Level: AAC - SDOH, AAC - Tobacco
  • Non-Bundled
  • Bundled
  • Dose 1
  • Dose 3
  • Dose 6
  • Dose 9
  • Dose 12
  • RPN
  • PPN

Treatment groups

1,560 Participants
are divided into 21 treatment groups

21

Treatment groups

See each treatment group below.

Sponsors and collaborators

University of Utah

Lead sponsor

National Cancer Institute (NCI)

Collaborator